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Background
Human immunodeficiency virus (HIV) from a family of
retroviruses is a causative organism for acquired
immuno deficiency syndrome (AIDS), affecting more
than 40 million people worldwide [1]. Reverse transcrip-
tion of the HIV single-stranded RNA genome into dou-
ble-stranded DNA is one of the essential key step in the
virus replication life-cycle and acts as lucrative target for
drug action. Till date, out of 20 anti-HIV drugs
approved for the treatment of HIV infection, eleven
approved anti-HIV drugs target RT, and encompass
t h r e ec l a s s e so fa g e n t st h a ti n h i b i tR Tb yd i f f e r e n t
mechanisms (Nucleoside Reverse Transcriptase Inhibi-
tors, NRTIs; Non-Nucleoside Reverse Transcriptase
Inhibitors, NNRTIs; Nucleotide Reverse Transcriptase
Inhibitors, NtRTIs) [2]. The NNRTIs serve as an
increasingly important role in the therapy of HIV infec-
tion, due to their unique antiviral potency, high specifi-
city and low toxicity. Present work illustrates the
probable binding affinity, interatomic contacts and
orientation of novel of NNRTIs in development at the
allosteric site of the HIV-RT through an iterative com-
putational process and molecular docking to explicate
the necessary structural requirement for rational drug
design.
Material and methods
Six NNRTIs in development were selected for the study
viz. Etravirine, Rilpivirine, Calanolide A, IDX899,
RDEA806 and Lersivirine). These selected molecules
were rigorously analyzed through Lipinski’sR u l eo f5
( R o 5 )b ym o l i n s p i r a t i o ns o f t w a r e[ 3 ] .I na no r d e rt o
explicate the binding affinity, interatomic contacts and
orientation of NNRTIs at the active of HIV-RT, a mole-
cular docking study were carried out by utilizing scoring
function such as PLP1, PLP2, Jain, PMF, Lig_Internal_E-
nergy, binding energy, and ultimately dock score. Dock-
ing study was performed by using the LigandFit as
docking module within package of Discovery Studio 2.5.
Position optimization of both ligand and proteins were
performed by using all-atom CHARMm forcefield with
Adopted Basis set Newton Raphson minimization algo-
rithm until the root mean square (r.m.s) gradient for
potential energy was less than 0.05 kcal/mol/Å. The cav-
ity within a receptor defined as active site and an input
site sphere was defined over the active site with a radius
of 5 Å.
Results
All six molecules successfully passed the Lipinski’sR o 5
filter to be as a probable drug candidate except some
minor violations. In terms of molecular docking, they
presented excellent scoring and binding affinity towards
the receptor due to the close interatomic contacts
through strong H-bonds Lys103 (Calanolide A), His235,
Tyr318 (RDEA806), Lys101 (Rilpivirine, Etravirine)
Val179 (Etravirine), pi-pi Tyr181 (IDX899, RDEA806,
Rilpivirine, Lersivirine) and pi-cation interactions
through Lys101 (RDEA806), Tyr103 (Rilpivirine).
Conclusion
As a concluding remark, preliminary screening by
Lipinski’s Ro5 acted as filter to obtain potential mole-
cule from large datasets, whereas, pi-pi interaction was
coined as a major interatomic interaction for stabilizing
* Correspondence: udaysingh98@gmail.com
1Department of Pharmaceutical Sciences, Sam Higginbottom Institute of
Agriculture Technology & Sciences, (Formerly Allahabad Agricultural Institute)
Deemed-to-be-University, Allahabad, India
Full list of author information is available at the end of the article
Singh and Singh Retrovirology 2011, 8(Suppl 2):P82
http://www.retrovirology.com/content/8/S2/P82
© 2011 Singh and Singh; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.receptor-ligand complex and minor with hydrogen
bonding and pi-cation interaction. We have anticipated
a pivotal facet for designing the next generation of
NNRTIs with improved activity based upon molecular
docking studies.
Acknowledgement
Financial assistance from Department of Biotechnology (DBT) and Indian
Council of Medical Research (ICMR), Government of India is sincerely
acknowledged.
Author details
1Department of Pharmaceutical Sciences, Sam Higginbottom Institute of
Agriculture Technology & Sciences, (Formerly Allahabad Agricultural Institute)
Deemed-to-be-University, Allahabad, India.
2Nucleic Acids Research
Laboratory, Department of Chemistry, University of Allahabad, Allahabad,
India.
Published: 3 October 2011
References
1. World Health Organisation: .[http://www.who.int/tb/hiv/faq/en/], Accessed
on 22/08/11.
2. Pawels R: New non-nucleoside reverse transcriptase inhibitors (NNRTIs)
in development for the treatment of HIV infections. Curr Opin Pharmacol
2004, 4:437-446.
3. Molinspiration: .[http://www.molinspiration.com/cgi-bin/properties].
doi:10.1186/1742-4690-8-S2-P82
Cite this article as: Singh and Singh: Molecular docking analysis of
novel Non-Nucleoside Reverse Transcriptase Inhibitors in development:
implication for rational drug design. Retrovirology 2011 8(Suppl 2):P82.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Singh and Singh Retrovirology 2011, 8(Suppl 2):P82
http://www.retrovirology.com/content/8/S2/P82
Page 2 of 2